Tenderwize
Back to tender search

Supply of Medicinal Products - Nivolumab

Centrum Onkologii im. Franciszka Łukaszczyka w Bydgoszczy·Bydgoszcz, Poland·Expired · Jul 31, 2026·Open·Supplies
Structured notice only
Original notice title

Poland – Antineoplastic agents – Dostawa produktów leczniczych- Nivolumabum

40/100

Opportunity Score

Needs reviewLow complexity
SuppliesExpired
Why this score?

Opportunity

40 / 100

Complexity

20 / 100

Risk factors

Estimated value is absent, hindering assessment of project size and financial viability.

Reverse procedure (evaluation before qualification) may lead to wasted effort if the highest bidder fails qualification.

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Tender facts

Contracting authority
Centrum Onkologii im. Franciszka Łukaszczyka w Bydgoszczy
Country
Poland
CPV
33652100 - Antineoplastic agents
Deadline
Jul 31, 2026

Overview

Moderate opportunity

Key Facts

  • Supplies contract
  • 1 lot
  • Duration 12 MONTH
  • Supply of Nivolumab (antineoplastic agent) to the contracting authority's hospital in Bydgoszcz.
  • Contract duration of 12 months.
Show full summary

Supply of antineoplastic agent Nivolumab to the Oncology Center in Bydgoszcz, Poland. Open procedure with single lot, 100% price award criterion. No estimated value provided. Requires authorization to trade pharmaceutical products. Potential reverse procedure (evaluation before qualification). EU funding flag present but conflicts with XML notice.

Risks

Estimated value is absent, hindering assessment of project size and financial viability.

Reverse procedure (evaluation before qualification) may lead to wasted effort if the highest bidder fails qualification.

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

  • Bidders must hold authorization to trade pharmaceutical products.

Administrative

  • Electronic submission is required via the platform Open portal
  • Tenders must be submitted in Polish language.

Requirements may be incomplete.

Award Criteria

Lot 1

Price 100% (per-exa) — 100%

Buyer

Location

Bydgoszcz, POL

Identifier

5542217419

Activity

Health

Lots (1)

LOT-0001

Supply of Medicinal Products - Nivolumab

Supply of Nivolumab for a 12-month period to Centrum Onkologii im. Franciszka Łukaszczyka w Bydgoszczy. Single lot, 100% price criterion. Requires authorization for pharmaceutical trading.

SuppliesEU fundedElectronic submissionSME suitable

Location

Bydgoszcz, Poland

Duration

12 MONTH

Category

Antineoplastic agents

Award Criteria

Price

Deadline

Expired Jul 31, 2026

Procurement Details

Publication date
30 Jun 2026
Languages
Polish

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
452486-2026

Documents (1)